Precision Peptide Company plans up to $2 million private placement Jun 11, 2026 05:02PM
The Precision Peptide Company Inc. Announces up to $2 Million LIFE Offering of Common Shares Jun 11, 2026 05:00PM
The Precision Peptide Company Establishes Compliant U.S. Peptide Access with Telehealth and Prescription Infrastructure Partnership Jun 9, 2026 07:30AM
The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC Jun 5, 2026 07:30AM
Precision Peptide signs US compounding pharmacy agreement Jun 2, 2026 07:02AM


Jun 2, 2026 07:00AM The Precision Peptide Company Inc. Signs Agreement with U.S.-Based 503A Sterile Compounding Pharmacy - Peptides to be 100% Compounded in the United States
May 28, 2026 07:30AM The Precision Peptide Company to Exhibit as the Only Peptide Company at Dave Asprey's BEYOND Conference in Austin, Texas
May 26, 2026 07:30AM The Precision Peptide Company Inc. Places Order for 20,000 BPC-157 Transdermal Patches
May 21, 2026 07:30AM The Precision Peptide Company (BPC) Expands on Exclusive 50/50 Revenue Share Peptide Partnership with MMA.INC (MMA)
May 19, 2026 07:02AM Precision Peptide's BPC-157 patch achieves 95.5% purity in lab tests
May 19, 2026 07:00AM The Precision Peptide Company (BPC) Lead Product Achieves 95.5% Purity in Independent Lab Testing, Clearing the Industry Benchmark and Advancing Toward Commercial Launch
May 14, 2026 07:30AM The Precision Peptide Company's Chief Scientific Officer Justin Kirkland to Be Featured on The Human Upgrade with Dave Asprey
May 12, 2026 08:31AM MMA.INC partners with Precision Peptide in 50/50 revenue share deal
May 12, 2026 07:30AM The Precision Peptide Company Inc. Announces Exclusive Strategic Marketing Partnership with Mixed Martial Arts Group Limited
May 7, 2026 07:35AM Precision Peptide nears launch of needle-free BPC-157 patch
May 7, 2026 07:30AM The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances
May 5, 2026 07:30AM C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises
May 4, 2026 07:30AM The Precision Peptide Company Grants RSUs and Stock Options and Settles Debt
Apr 23, 2026 08:00AM The Precision Peptide Company Announces Strategic Product Marketing Agreement
Apr 16, 2026 07:30AM The Precision Peptide Company Applauds FDA Action Advancing Regulatory Clarity for Peptide Therapies
Apr 15, 2026 08:00AM The Precision Peptide Company Announces Public Relations and Consulting Services Agreement